Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Tangen Biosciences, Inc. See All Filings	D	2023-06-06 13:37:43 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0001661955 Filed Document 0001934002-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-06-06 13:37:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Debt
Tangen Biosciences, Inc. See All Filings	D	2020-07-01 09:00:58 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001661955 Filed Document 0001661955-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-07-01 09:00:58 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Tangen Biosciences, Inc. See All Filings	D	2019-03-22 10:35:22 UTC
Amount To Be Raised $11,069,342 Associated Brokers / Dealers N/A CIK Number 0001661955 Filed Document 0001661955-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-03-22 10:35:22 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Tangen Biosciences, Inc. See All Filings	D	2016-11-02 15:13:02 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0001661955 Filed Document 0001661955-16-000001 Exclusions or Exemptions 506c Accepted Date 2016-11-02 15:13:02 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Tangen Biosciences, Inc. See All Filings	D	2015-12-28 00:00:00 UTC
Amount To Be Raised $3,030,403 Associated Brokers / Dealers N/A CIK Number 0001661955 Filed Document 0001209191-15-087149 Exclusions or Exemptions 506b Accepted Date 2015-12-28 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity